Therapeutic potential of mitotic kinesin inhibitors in cancer
Authors:
- Kenji MatsunoKMKenji Matsuno
- Jun-Ichi SawadaJSJun-Ichi Sawada
- Akira AsaiAAAkira Asai
- 16 March 2008
- journal article
- Published by Informa Healthcare in Expert Opinion on Therapeutic Patents
- Vol. 18 (3) , 253-274
Abstract
Background: Mitotic kinesins are attractive targets in cancer chemotherapy. A large number of small-molecule inhibitors of kinesin spindle protein (KSP) and centromere-associated protein E (CENP-E) have been discovered. Objective: To estimate the therapeutic potential of mitotic kinesin inhibitors. Methods: We comprehensively summarized and analysed the trend among recent patents and conducted a literature review of clinical trials performed since July 2004. Results/conclusion: More than 80 patent applications have been made, spanning a wide range of structural diversity. Five KSP inhibitors and one CENP-E inhibitor have advanced to the early clinical stage, and some of the results for these clinical trials have been disclosed. The therapeutic potential for mitotic kinesin inhibitors is likely to become obvious within the next few years.Keywords
This publication has 70 references indexed in Scilit:
- Docking studies on kinesin spindle protein inhibitors: an important cooperative ‘minor binding pocket’ which increases the binding affinity significantlyJournal of Molecular Modeling, 2007
- An Inhibitor of the Kinesin Spindle Protein Activates the Intrinsic Apoptotic Pathway Independently of p53 and De Novo Protein SynthesisMolecular and Cellular Biology, 2007
- Human Kinetochore-associated Kinesin CENP-E Visualized at 17 Å Resolution Bound to MicrotubulesJournal of Molecular Biology, 2006
- The bipolar mitotic kinesin Eg5 moves on both microtubules that it crosslinksNature, 2005
- Gene Silencing of CENP-E by Small Interfering RNA in HeLa Cells Leads to Missegregation of Chromosomes after a Mitotic DelayMolecular Biology of the Cell, 2004
- Activating and Silencing the Mitotic Checkpoint through CENP-E-Dependent Activation/Inactivation of BubR1Cell, 2003
- Small Molecule Inhibitor of Mitotic Spindle Bipolarity Identified in a Phenotype-Based ScreenScience, 1999
- A bipolar kinesinNature, 1996
- Modulation of CENP-E organization at kinetochores by spindle microtubule attachmentCell Motility, 1996
- Phosphorylation by p34cdc2 regulates spindle association of human Eg5, a kinesin-related motor essential for bipolar spindle formation in vivoCell, 1995